Dermatology: Practical and Conceptual Original Article | Dermatol Pract Concept. 2024;14(3):e2024198 1 Acne Keloidalis Nuchae: A Multicenter Retrospective Study of 142 Hispanic Patients Luis E. Sánchez-Dueñas1, Mariana G. Ungson-García2, Joel Alejandro Ramírez-Sánchez3, Antonio Michell Ayala Barrera4, Miguel Marti Machado5, Sonia Sofía Ocampo-Garza6, Lizet K. Rojano-Fritz7, Aldo Gálvez-Canseco8, Lidia Elena Bernal López9, Daniela Gutierrez Mendoza10, Roxana Castañeda Yepiz11, Araceli Alvarado Delgadillo12, Yakelin Morales Miranda13 1 Dermatology Department, Dermika Centro Dermatológico Láser, Guadalajara, Mexico 2 Dermatology Department, Hospital Regional “Dr. Valentín Gómez Farías”, Guadalajara, Mexico 3 Dermatology Department, Instituto Dermatológico de Jalisco “Dr. José Barba Rubio”, Guadalajara, Mexico 4 Instituto Tecnológico y de Estudios Superiores de Monterrey, Guadalajara, Mexico 5 Dr. Marti, Hair and Scalp Diseases Group, Buenos Aires, Argentina 6 Dermatology Department, Universidad Autónoma de Nuevo León, Hospital Universitario “Dr. José Eleuterio González”, Monterrey, Mexico 7 Private Practice, Barranquilla, Colombia 8 Private Practice, Lima, Perú 9 Private Practice, Hospital General “Dr. Manuel Gea Gonzalez”, CDMX, Mexico 10 Private Practice, Tijuana, Mexico 11 Private Practice, Tijuana, Mexico 12 Centro Especializado en Enfermedades de la Piel (CEEPIEL), Hidalgo, Mexico 13 Private Practice, Hospital Angeles Lomas, CDMX, Mexico Key words: acne keloid, folliculitis keloidalis nuchae, Hispanic or Latino, follicular occlusive disorders Citation: Sánchez-Dueñas LE, Ungson-García MG, Ramírez-Sánchez JA, et al. Acne Keloidalis Nuchae: A Multicenter Retrospective Study of 142 Hispanic Patients. Dermatol Pract Concept. 2024;14(3):e2024198. DOI: https://doi.org/10.5826/dpc.1403a198 Accepted: March 25, 2024; Published: July 2024 Copyright: ©2024 Sánchez-Dueñas et al. This is an open-access article distributed under the terms of the Creative Commons Attribution- NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing Interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding Author: Luis E. Sánchez-Dueñas, MD, Dermatology Department, Dermika Centro Dermatológico Láser, Golfo de Cortés 3002, Col. Vallarta Norte Guadalajara, Jalisco, 44280, México. E-mail: luis.sanchez@dermika.com.mx Introduction: Acne keloidalis nuchae (AKN) is a primary cicatricial alopecia with mixed infiltrate. It is more common in Africans or persons of African descent. Objectives: Our objective was to describe the epidemiology and clinical and trichoscopic presentations of AKN in a large series of Hispanic patients. ABSTRACT 2 Original Article | Dermatol Pract Concept. 2024;14(3):e2024198 Introduction Acne keloidalis nuchae (AKN), also known as folliculitis ke- loidalis nuchae, is a chronic scalp disease first described by Hebra in 1860. AKN mainly affects young male patients (20:1), especially African patients or those of African descent [1]. This scarring alopecia begins in the nuchae region with papules and pustules that may evolve to nodules and plaques [1,2]. In severe cases, keloid-like hypertrophic masses occur [1,2]. The etiology of AKN remains unclear, the most widely accepted theory being an immune response leading to incip- ient folliculitis caused by local trauma from razor use in the nuchal area or use of a helmet, but also by ingrown hairs due to the kinky nature of the hair and curvature of the follicular type, which is more prevalent in the African American pop- ulation [1-5]. Some studies have suggested a genetic, meta- bolic, and hormonal component in the development of this condition, but none has been proven [6-9]. The trichoscopic features have been described, such as hair tuft and loss of follicular ostia, but these findings are not pathognomonic either [10,11]. Most studies on AKN have been performed in patients of African descent, and it is likely that racial factors are critical to disease development and response to treatment [1-3]. Objective The aim of this study was to describe the epidemiology and clinical and trichoscopic characteristics of Hispanic patients with AKN. Methods This was a retrospective study involving patients from 10 different dermatological centers in Argentina, Colombia, Mexico, and Peru with a clinical diagnosis of AKN or folliculitis keloidalis nuchae, from 2018 to 2022. The medi- cal records of the patients with AKN were reviewed and reg- istered in a database for further statistical analyses. Clinical evaluation was performed by 12 dermatologists experienced in trichology. The Umar classification was used to determine the severity accordingly: • Distribution: class I: occipital area (OA) < 3 cm, class II: OA > 3 cm < 6.5 cm, class III: OA > 6.5 cm, class IV: be- yond the occipital notch. • Morphology: discrete papules and nodules, merged pap- ules and nodules, plaque, or tumorous mass. Associated diseases were also investigated, such as follicu- litis decalvans (FD), dissecting cellulitis (DC), or pseudofollic- ulitis barbae (PFB). Trichoscopic analysis was performed using manual dermoscopy (DermLite) or digital dermoscopy (Foto- Finder) devices. The data procured were subjected to descrip- tive statistics analyses (medians, ranges, and proportions) and inferential statistics (Fisher’s exact test and Chi-square test). Results In ten clinical dermatology centers in Argentina, Colombia, Peru, and Mexico, 142 patients with AKN were identified (Table 1): 140 were male (98.6%) and two were female (1.4%). The age at onset ranged from 18 to 41 years, with a mean of 32 years. Two patients were Caucasian (1.4%), one was of African American descent (0.7%), and the remaining 139 were Hispanic (97.8%). In terms of personal history, 108 patients had a his- tory of trauma to the nuchal area (76%, P < 0.001) and 48 had a history of acne (33.8%, P = 0.021). Interestingly, in addition to the AKN diagnosis, 10 patients were diag- nosed with FD (7%), eight with PFB (5.6%), three with DC (2.1%), and one with hidradenitis suppurativa (HS) (0.7%, n=1). Only seven patients had other non-dermatological Methods: This was a retrospective study from 10 different dermatological centers in Argentina, Colombia, Mexico, and Peru. Patients with a clinical diagnosis of AKN treated by 12 dermatologists experienced in trichology from 2018 to 2022 were included. The Umar classification system was used to determine severity. Results: We identified 142 patients with AKN: 98% were male (n=140) with a mean age of 32 years; 108 patients had a previous history of trauma to the nuchal area (76%, P < 0.001); and 48 were positive for a history of acne (33.8%, P = 0.021). Patients with >50 months of evolution were mainly classified in classes III and IV compared to patients with an evolution of <50 months (30%, n=9 vs. 14%, n=15; P = 0.019; respectively). Conclusion: AKN should be considered in the differential diagnosis in the Hispanic population. Advanced stages of the disease are correlated with chronic evolution. Original Article | Dermatol Pract Concept. 2024;14(3):e2024198 3 Table 1. Comparisons of Demographics and Clinical Characteristics for Our Study Sample With Findings from Umar et al. [3] and Lobato-Berezo et al. [11] Statistical Values Variables Statistics/Categories Our Study Sample Umar et al. (2021) Lobato-Berezo et al. (2023) Demographic Sex: N (%) Male 140 (98.6) 100 (100) 75 (94.94) Female 2 (1.4) - 4 (5.06) Ethnicity: N (%) Hispanic 139 (97.8) 40 (37) 11 (14.29) Caucasian 2 (1.4) 0 (0) 32 (41.56) African American 1 (0.7) 62 (58) 9 (11.69) Middle Eastern - 2 (2) 6 (7.79) Asian - 3 (3) 4 (5.19) African - - 15 (19.48) Medical history Acne, n (%) 48 (33.8) 42 (39) 11 (14.29) FD, n (%) 10 (7) 7 (7) 16 (20.25) DC, n (%) 3 (2.1) 1 (1) 5 (6.33) PFB, n (%) 8 (5.6) - 15 (19.48%) Clinical classification Lesion distribution Class I, n (%) 71 (50) 17 (16) 32 (41.03) Class II, n (%) 45 (31.6) 63 (58) 26 (33.33) Class III, n (%) 21 (14.7) 21 (19) 20 (25.64) Class IV, n (%) 5 (3.5) 7 (7) 0 (0.00) Lesion type Discrete papules/nodules, n (%) 14 (9.8) 2 (2) 46 (58.97) Merge Papules/Nodules, n (%) 101 (71.1) 48 (44) 14 (17.95) Plaque, n (%) 21 (14.7) 40 (37) 9 (11.54) Tumorous Mass, n (%) 6 (4.2) 18 (17) 9 (11.54) Main trichoscopic findings Tufted Hairs, n (%) 60 (42.2) - - Erythema, n (%) 80 (56.3) - - Pustules, n (%) 69 (48.5) - - Treatment Antibiotics, n (%) 58 (41) 29 (27) 44 (56.41) Oral retinoids, n (%) 19 (13) 2 (2) 47 (60.26) Laser, surgery and ablation, n (%) 4 (2.8) 7 (7) 10 (12.66) Topical steroids, n (%) 21 (19) 8 (7) 28 (35.90) Systemic steroids, n (%) 5 (3.5) - 7 (8.97) Intralesional steroids, n (%) 20 (14) 45 (42) 48 (61.54) *One patient from Dr. Umar had no ethnicity listed. DC = dissecting cellulitis; FD = folliculitis decalvans; PFB = pseudofolliculitis barbae. comorbidities (4.9%), all of whom were diagnosed with dys- lipidemia (100%, n=7). The main distribution corresponded to classes I and II of the Umar classification system (Figures 1 and 2), with 116 identified in these classes (81.6%), class III with 21 patients (14.7%) (Figures 3 and 4), and class IV with five patients (3.5%). The main clinical lesions were papules and nodules, which were found in 115 (80.9%), plaque in 21 patients 4 Original Article | Dermatol Pract Concept. 2024;14(3):e2024198 surgery were performed in four of the patients (2.8%) (Figure 4 A and B). The patients were divided into two groups according to the chronicity of their disease: 1) patients with an evolution of ≤50 months, and 2) patients with an evolution time >50 months. We found that most patients who had >50 months of evolution of the disease were mainly classes III and IV compared to patients with an evolution of ≤ 50 months (14.7%), and tumorous mass in six patients (4.2%) (Figures 3 and 4). Regarding the trichoscopic findings, we found that 80 patients had diffuse erythema (56.3%), 69 patients had pustules (48.6%), and 60 patients had tufted hairs (42.2%) (Figure 2). In addition, 65 of the patients with diffuse ery- thema were classified as either class I or II (81.25%, n=80). The most common treatment among all patients was systemic antibiotic in 31 patients (21.8%). Laser and Figure 2. (A) A 32-year-old male with acne keloidalis nuchae class III, tumorous mass, (B) Trichos- copy: perifollicular scale, unstructured red areas, unstructured white areas, and tufted hairs. Figure 3. (A) A 25-year-old male with acne keloidalis nuchae class III, grouped papules and nodules associated with dissecting cellulitis. (B) Trichoscopy: perifollicular erythema, unstructured red areas, unstructured white areas, and tunneled hairs. Figure 1. (A) A 24-year-old male with acne keloidalis nuchae, class I, discrete papules and nodules. (B, C) Trichoscopy: follicular papules with dotted vessels and follicular pustules. Original Article | Dermatol Pract Concept. 2024;14(3):e2024198 5 We were able to identify the following trichoscopic findings: follicular papules with hair shafts, follicular pap- ules with dotted vessels, follicular pustules, perifollicular erythema, perifollicular scale, unstructured red areas, un- structured white areas, tunneled hairs, yellowish crusts, and tufted hairs. Interestingly, most patients in classes III and IV had tufted hairs, suggesting that there is a higher chance of identifying this trichoscopic finding in a wider distribution of AKN. In classes I and II, the erythema and pustules were the most frequent trichoscopic findings (Table 1). AKN represents a therapeutic challenge because none of the available treatments has been shown to be reliable in all patients [6]. Medical therapy (mainly with antibiot- ics, steroids, and retinoids), laser therapy (Nd:YAG, CO2 and diode), cryosurgery, and surgical approaches are the main therapies currently used (Figures 4A and 3B) [1,2,3]. In our study, systemic antibiotic treatment was the most used ther- apy (Table 1). However, all of them have different response rates, and relapse may occur [1,3]. Limitations The limitations of this study are its retrospective nature and the lack of histopathologic correlation. Further studies may help establish criteria to differentiate AKN from other follic- ular occlusive diseases. Conclusions AKN is a complex disease that should be considered not only as a single entity, but also as a scarring alopecia within other follicular occlusive diseases such as acne, DC, and HS. AKN is a disease that could be more common than what we think in the Hispanic population, and further studies in specific populations are required to establish specific risk factors. Most patients within classes III and IV had tufted hairs, suggesting that there is a higher chance of identifying (30%, n=9 vs. 14%, n=15; P = 0.019; respectively). The other comparisons were not statistically significant. Discussion Our results showed that male was the predominant sex af- fected by AKN in the Hispanic population, with a mean age at onset of 32 years, which is consistent with reports from other studies [7-11]. Shaving of the nape of the neck was the main risk factor, in agreement with similar studies in other populations, reflecting mechanical trauma also observed in patients wearing helmets [1,2]. Recently, Umar et al. reported a classification system for AKN: 1) based on the distribution of lesions in terms of the area between two lines parallel to the occipital prominence and mastoid processes, defined in classes I to IV, and 2) ac- cording to the type of lesions in isolated papules/nodules, grouped papules/nodules, plaques, and tumorous masses [5]. This classification provides an objective clinical description of patients with AKN and assesses the subsequent response to treatment [5]. Patients who reported a risk factor for the disease were classified as either class I or II (88.8%, n=108), suggesting that this acts as a trigger for the development of the disease (Table 1). We found that patients classified as class IV, with extension beyond the occipital notch, had >50 months of evolution. We hypothesize that Hispanic patients may evolve to a more extensive disease over time, which is different from what other studies have reported and that that AKN remains stable over time. Follicular occlusive disorders such as acne vulgaris/con- globata, DC, and HS occurred in 52 patients (36.6%), which was similar to that reported by East-Innis et al. (37%) and Lobato-Berezo et al., who also reported a prevalence of 37.2% for this group of disorders (Table 1) [5,10,12]. The most com- mon skin disease related in our study was acne vulgaris (33%), followed by FD (7%). In contrast, PFB was less frequent (5%) in our population than in other reports [5,10,12]. Figure 4. (A) A 65-year-old male with acne keloidalis nuchae, 10-year history, class III, tumorous mass. (B) Results after surgical removal of tumoral mass and secondary intention healing. 6 Original Article | Dermatol Pract Concept. 2024;14(3):e2024198 7. Loayza E, Cazar T, Uraga V, Lubkov A, Garces JC. Acne keloi- dalis nuchae in Latin American women. Int J Dermatol. 2015; 54(5):e183-5. doi: 10.1111/ijd.12092. 8. Kridin K, Solomon A, Tzur-Bitan D, Damiani G, Comaneshter D, Cohen AD. Acne keloidalis nuchae and the metabolic syndrome: a population-based study. Am J Clin Dermatol. 2020;21(5): 733-739. doi: 10.1007/s40257-020-00541-z. 9. Matsunaga AM, Tortelly VD, Machado CJ, Pedrosa LR, Melo DF. High Frequency of Obesity in Acne Keloidalis Nuchae Patients: A Hypothesis from a Brazilian Study. Skin Appendage Disord. 2020 Nov;6(6):374-378. doi:10.1159/000509203. 10. East-Innis ADC, Stylianou K, Paolino A, Ho JD. Acne keloida- lis nuchae: risk factors and associated disorders - a retrospec- tive study. Int J Dermatol. 2017;56(8):828-832. doi: 10.1111 /ijd.13678. 11. Na K, Oh SH, Kim SK. Acne keloidalis nuchae in Asian: A single institutional experience. PLoS One. 2017;12(12):e0189790. doi: 10.1371/journal.pone.0189790. 12. Lobato-Berezo A, Escolà-Rodríguez A, Courtney A, et al. Acne keloidalis nuchae: An international multicentric review of 79 patients. J Eur Acad Dermatol Venereol. 2023. doi: 10.1111 /jdv.19609. 13. Chouk C, Litaiem N, Jones M, Zeglaoui F. Acne keloidalis nu- chae: clinical and dermoscopic features. BMJ Case Rep. 2017; 2017:bcr2017222222. doi: 10.1136/bcr-2017-222222. this trichoscopic finding in a widespread disease. Advanced stages of the disease correlate with chronic evolution. References 1. Ogunbiyi A. Acne keloidalis nuchae: prevalence, impact, and management challenges. Clin Cosmet Investig Dermatol. 2016;9: 483-489. doi: 10.2147/CCID.S99225. 2. Adegbidi H, Atadokpede F, do Ango-Padonou F, Yedomon H. Keloid acne of the neck: epidemiological studies over 10 years. Int J Dermatol. 2005;44 Suppl 1:49-50. doi: 10.1111/j.1365 -4632.2005.02815.x. 3. Maranda EL, Simmons BJ, Nguyen AH, Lim VM, Keri JE. Treat- ment of acne keloidalis nuchae: a systematic review of the litera- ture. Dermatol Ther (Heidelb). 2016;6(3):363-78. doi: 10.1007 /s13555-016-0134-5. 4. Shapero J, Shapero H. Acne keloidalis nuchae is scar and keloid formation secondary to mechanically induced folliculitis. J Cutan Med Surg. 2011;15(4):238-40. doi: 10.2310/7750.2011.10057. 5. Umar S, Lee DJ, Lullo JJ. A retrospective cohort study and clini- cal classification system of acne keloidalis nuchae. J Clin Aesthet Dermatol. 2021;14(4):E61-E67. 6. Loayza E, Vanegas E, Cherrez A, Cherrez Ojeda I. Acne keloidalis nuchae in Latin America: is there a different phenotype? Int J Dermatol. 2017;56(12):1469-1470. doi: 10.1111/ijd.13783.